March 2, 2026

Revvity, Inc. (RVTY) Stock Analysis: Unveiling a 21.62% Potential Upside in the Healthcare Sector

Revvity, Inc. (RVTY), a prominent player in the healthcare sector, operates within the diagnostics and research industry. Headquartered in Waltham, Massachusetts, Revvity offers a suite of..

argenx SE (ARGX) Stock Analysis: A Biotech Giant with 33% Upside Potential

argenx SE (NASDAQ: ARGX) has become a notable name in the biotechnology sector, capturing investor attention with its expansive pipeline and robust market presence. Based in..

Labcorp Holdings Inc. (LH) Stock Analysis: Strong Buy Ratings and Strategic Expansion Drive Investor Interest

Labcorp Holdings Inc. (NYSE: LH) is a prominent player in the healthcare sector, specifically within the diagnostics and research industry. The company stands out in its..

Stevanato Group S.p.A. (STVN) Stock Analysis: Exploring a Promising 79% Upside Potential

Stevanato Group S.p.A. (NYSE: STVN), a leading player in the healthcare sector, is drawing significant attention from investors due to its robust growth prospects and a..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Navigating Opportunities in the Medical Devices Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, continues to capture attention with its diverse portfolio in the medical devices industry...

Illumina, Inc. (ILMN) Stock Analysis: Exploring the Upside with a 33% Return on Equity

Illumina, Inc. (NASDAQ: ILMN) continues to be a fascinating player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of..

Fidelity Special Values January update – shares rise on improving UK growth narrative

Fidelity Special Values PLC reported NAV and share price returns of 26.7% and 39.1% respectively over the 12 months to 31 January 2026, outperforming the FTSE..

Summit Therapeutics Inc. (SMMT) Stock Analysis: Biotech Innovator with an 89.92% Potential Upside

Investors have their eyes on Summit Therapeutics Inc. (NASDAQ: SMMT), a dynamic player in the biotechnology sector, as the company continues to make strides in developing..

Ascendis Pharma A/S (ASND) Stock Analysis: A Biotech Contender with 20% Upside Potential

Ascendis Pharma A/S (NASDAQ: ASND) is making waves in the biotechnology sector, offering promising growth prospects for investors keen on healthcare innovations. The Danish-based biopharmaceutical company..

Biogen Inc. (BIIB) Stock Analysis: Evaluating the 7.22% Upside Potential Amidst Market Dynamics

Biogen Inc. (NASDAQ: BIIB), a prominent player in the healthcare sector specializing in drug manufacturing, currently presents a noteworthy opportunity for investors, with its potential upside..

Halozyme Therapeutics, Inc. (HALO) Stock Analysis: Unlocking a 21.53% Potential Upside

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a prominent player in the biotechnology sector, has been making waves in the healthcare industry with its innovative approaches to drug..

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: Robust Analyst Ratings Signal Potential 51.69% Upside

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM), a commercial-stage biopharmaceutical company headquartered in Boston, Massachusetts, is drawing significant attention from investors. Specializing in rare neuroendocrine diseases, Rhythm Pharmaceuticals..

Vaxcyte, Inc. (PCVX)

⚠️ No article content returned.

..

Centene Corporation (CNC) Stock Analysis: Navigating Healthcare Growth Amidst Challenges

Investors eyeing Centene Corporation (NYSE: CNC) may find themselves intrigued by the company’s substantial market presence in the healthcare sector, yet wary of its current valuation..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Analyst Consensus and 12% Upside Potential

Prestige Consumer Healthcare Inc. (NYSE: PBH), a key player in the healthcare sector, has drawn attention from investors with its strong portfolio of over-the-counter (OTC) health..

Repligen Corporation (RGEN) Investor Outlook: Exploring a 44.7% Potential Upside in the Bioprocessing Sector

Repligen Corporation (NASDAQ: RGEN), a key player in the healthcare sector focusing on medical instruments and supplies, presents a captivating investment opportunity with a notable potential..

BioNTech SE (BNTX) Investor Outlook: Analyzing a 25.91% Potential Upside Amid Robust Pipeline

BioNTech SE (NASDAQ: BNTX) stands as a beacon in the biotechnology industry, particularly known for its contributions to immunotherapy for cancer and infectious diseases. The German-based..

Masimo Corporation (MASI) Stock Analysis: Navigating Growth in the Medical Devices Sector

Masimo Corporation (NASDAQ: MASI) stands at the forefront of the healthcare industry with its innovative medical devices and patient monitoring technologies. Based in Irvine, California, Masimo..

Corcept Therapeutics (CORT) Stock Analysis: Exploring an 83% Potential Upside in the Biotech Sector

Corcept Therapeutics Incorporated (NASDAQ: CORT) has recently caught the attention of investors, with an impressive potential upside of 83.19% as indicated by analyst target prices. This..

Integer Holdings Corporation (ITGR) Stock Report: Evaluating Growth Potential in the Medical Devices Sector

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, particularly within the medical devices industry, presents a compelling investment opportunity for those eyeing..

Search

Funds

March 2, 2026

Fidelity Special Values January update – shares rise on improving UK growth narrative

Fidelity Special Values PLC reported NAV and share price returns of 26.7% and 39.1% respectively over the 12 months to 31 January 2026, outperforming the FTSE All-Share Index...
Search

Funds

March 2, 2026

FTSE 100

Funds